15 hours ago
Stocks slid Wednesday afternoon after Federal Reserve Chair Kevin Warsh followed the central bank's first rate hike in three years with a press conference that hinted it wouldn't be the last.
The S&P 500 dropped 1%, heading toward its lowest close since July. The Dow Jones Industrial Average fell 1.7%, or more than 700 points, with financial shares leading the decline. The Nasdaq Composite fell 0.8%. The 10-year Treasury yield held near 5% a day after touching its highest level since 2007, and the dollar index climbed 0.6% to its strongest since late July.
Markets had priced in the quarter-point increase itself and initially took it in stride. All three indexes were higher before the 2 p.m. decision. The selling started during the press conference.
Warsh was on a tightrope going in. The question was whether he'd frame the hike as a one-off adjustment—which risked the bond market reading it as too little to deter inflation—or as the start of a longer cycle. He did neither, and instead went in a more hawkish direction. "I would be hard pressed to describe broad financial conditions as restrictive," he said in his opening remarks. "This view was widely shared by the committee, so we removed a dose of accommodation."
That's a new way of describing a rate hike, and one investors aren't used to. Under his predecessor, Jerome Powell, the Fed called policy "modestly restrictive," meaning rates were already high enough to slow the economy. Warsh was saying that at 3.5%–3.75%, they weren't—and by implication, one quarter point may not have gotten them there either. Asked directly, he declined to say whether policy is restrictive now.
#hike #press
The S&P 500 dropped 1%, heading toward its lowest close since July. The Dow Jones Industrial Average fell 1.7%, or more than 700 points, with financial shares leading the decline. The Nasdaq Composite fell 0.8%. The 10-year Treasury yield held near 5% a day after touching its highest level since 2007, and the dollar index climbed 0.6% to its strongest since late July.
Markets had priced in the quarter-point increase itself and initially took it in stride. All three indexes were higher before the 2 p.m. decision. The selling started during the press conference.
Warsh was on a tightrope going in. The question was whether he'd frame the hike as a one-off adjustment—which risked the bond market reading it as too little to deter inflation—or as the start of a longer cycle. He did neither, and instead went in a more hawkish direction. "I would be hard pressed to describe broad financial conditions as restrictive," he said in his opening remarks. "This view was widely shared by the committee, so we removed a dose of accommodation."
That's a new way of describing a rate hike, and one investors aren't used to. Under his predecessor, Jerome Powell, the Fed called policy "modestly restrictive," meaning rates were already high enough to slow the economy. Warsh was saying that at 3.5%–3.75%, they weren't—and by implication, one quarter point may not have gotten them there either. Asked directly, he declined to say whether policy is restrictive now.
#hike #press
17 hours ago
October Nymex natural gas (NGV26) on Wednesday closed down -0.028 (-0.96%).
Nat-gas prices retreated from a 1-week high on Wednesday and settled lower as a decline in European nat-gas prices to a 1-week low sparked long liquidation in US nat-gas futures. Nat-gas prices initially rose on Wednesday on the outlook for above-average US temperatures, which should boost nat-gas demand from electricity providers as air conditioning use is expected to increase. The Commodity Weather Group said Wednesday that above-average temperatures are expected across the South and Southeast through September 25.
Crude Oil Prices Sharply Lower as Middle East Disruptions Ease
Crude Oil Prices Retreat as Supply Fears Ease
Why UBS Just Turned Bearish on NuScale Power Stock
#prices #lower #average #expected
Nat-gas prices retreated from a 1-week high on Wednesday and settled lower as a decline in European nat-gas prices to a 1-week low sparked long liquidation in US nat-gas futures. Nat-gas prices initially rose on Wednesday on the outlook for above-average US temperatures, which should boost nat-gas demand from electricity providers as air conditioning use is expected to increase. The Commodity Weather Group said Wednesday that above-average temperatures are expected across the South and Southeast through September 25.
Crude Oil Prices Sharply Lower as Middle East Disruptions Ease
Crude Oil Prices Retreat as Supply Fears Ease
Why UBS Just Turned Bearish on NuScale Power Stock
#prices #lower #average #expected
19 hours ago
Brace for minor market tremors now that the Fed has hiked interest rates by 0.25%.
Although if history holds up, any losses could prove short-lived.
The S&P 500 (^GSPC) has declined by an average of 4.0% over the six weeks following the first Fed rate hike of a cycle across seven such episodes since 1988, per new ****** ysis from strategists at The Kobeissi Letter.
Stocks recovered all of those losses over the next five to six weeks on average.
In the six months following the first interest rate hike, the S&P 500 returned 4% on average. After 12 months, the S&P 500's average gain tallied 9%. Positive returns have occurred in every episode except 2022 over the 12 months.
"Fed rate hikes have historically been great buying opportunities," the strategists added.
Read more: Follow live coverage of the Fed meeting
The decision by the Fed to lift rates comes as sticky inflation readings — from the CPI to PPI — and rising energy costs force central bankers back into tightening mode. The rate hike marks the central bank's first interest rate increase since July 2023.
Investors are also focused on the updated economic projections and the Fed's "dot plot" to gauge future moves on rates — said dot plot didn't rule out one more hike this year. A hawkish dot plot as was received and follow up commentary from Fed Chairman Kevin Warsh could further elevate borrowing costs and pressure stocks initially around the world.
#rate #hike #first #plot
Although if history holds up, any losses could prove short-lived.
The S&P 500 (^GSPC) has declined by an average of 4.0% over the six weeks following the first Fed rate hike of a cycle across seven such episodes since 1988, per new ****** ysis from strategists at The Kobeissi Letter.
Stocks recovered all of those losses over the next five to six weeks on average.
In the six months following the first interest rate hike, the S&P 500 returned 4% on average. After 12 months, the S&P 500's average gain tallied 9%. Positive returns have occurred in every episode except 2022 over the 12 months.
"Fed rate hikes have historically been great buying opportunities," the strategists added.
Read more: Follow live coverage of the Fed meeting
The decision by the Fed to lift rates comes as sticky inflation readings — from the CPI to PPI — and rising energy costs force central bankers back into tightening mode. The rate hike marks the central bank's first interest rate increase since July 2023.
Investors are also focused on the updated economic projections and the Fed's "dot plot" to gauge future moves on rates — said dot plot didn't rule out one more hike this year. A hawkish dot plot as was received and follow up commentary from Fed Chairman Kevin Warsh could further elevate borrowing costs and pressure stocks initially around the world.
#rate #hike #first #plot
1 day ago
Updated on: September 16, 2026 / 5:45 PM EDT / CBS/AP
Scientists have discovered a crater on the moon that's bigger than the Roman Colosseum and is the result of a powerful impact two years ago that initially went undetected.
The steep-sided hole measured about 728 feet across, the length of two football fields, and up to 141 feet deep, equivalent to three vertically stacked yellow school buses, according to NASA. It's the solar system's biggest known impact crater carved out in recent times.
Such a large-scale event is estimated to occur only once every 132 years, researchers said, making this a treasure trove of information as NASA prepares to build a base for astronauts on the moon.
"This event constitutes a statistically rare, effectively once-in-a-lifetime observation," the scientists wrote in one of two studies appearing on the subject Wednesday in the journal Science Advances.
#crater
Scientists have discovered a crater on the moon that's bigger than the Roman Colosseum and is the result of a powerful impact two years ago that initially went undetected.
The steep-sided hole measured about 728 feet across, the length of two football fields, and up to 141 feet deep, equivalent to three vertically stacked yellow school buses, according to NASA. It's the solar system's biggest known impact crater carved out in recent times.
Such a large-scale event is estimated to occur only once every 132 years, researchers said, making this a treasure trove of information as NASA prepares to build a base for astronauts on the moon.
"This event constitutes a statistically rare, effectively once-in-a-lifetime observation," the scientists wrote in one of two studies appearing on the subject Wednesday in the journal Science Advances.
#crater
2 days ago
Steel and materials markets fluctuated between rallies and pullbacks as the US-Canada trade relationship shifted from near agreement to open dispute. Nucor Corporation (NYSE:NUE) and Cleveland-Cliffs Inc. (NYSE:CLF) rose on August 25, after discussions between the two countries broke down, a turnaround from the week before, when several of the same stocks fell on hopes that a new deal would decrease steel and aluminum tariffs. The VanEck Steel ETF gained 1.6% on the day, while the State Street Materials Select Sector SPDR reached an intraday high. The rise didn't last: by the end of the week, the materials ETF had slipped to negative territory, while the steel ETF was about flat, though, both remain substantially up for 2026.
The volatility traces a rapid escalation. On August 19, Bloomberg reported that the US and Canada had tentatively agreed to reduce tariffs on Canadian steel and aluminum to 25% and vehicle charges to 15%. That optimism was dashed within days: on August 22, the US imposed 50% tariffs on a wide variety of Canadian exports, and Canadian Prime Minister Mark Carney responded by declaring Canada officially "at war" with the United States, saying "You're at war when you're attacked, and we got attacked."
On August 25, Ottawa announced counter-tariffs of C$27.6 billion on American goods, which took effect on September 8 at rates ranging from 15% to 50%. The dispute has continued to escalate since then, with Washington announcing additional restrictions and tariffs on Canadian goods in September, reinforcing the view that a quick resolution remains unlikely.
Atsi Sheth, Moody's chief credit officer, put it bluntly: "Expect much more of this uncertainty for some time to come." Investors initially welcomed tariffs as good news for US steelmakers facing less Canadian competition, but the back-and-forth negotiations, as well as Canada's reaction, have made predicting a steady outcome difficult.
The more intriguing story is how differently the aforementioned companies are positioned. Nucor Corporation (NYSE:NUE) relies primarily on scrap-based electric arc furnace steelmaking, while Cleveland-Cliffs Inc. (NYSE:CLF) operates a vertically integrated model with internally sourced iron ore, scrap and other raw materials. Both have meaningful domestic raw-material exposure, although their production models differ substantially. Nucor Corporation (NYSE:NUE) is up more than 50% year-to-date, while Cleveland-Cliffs Inc. (NYSE:CLF), despite similar structural insulation, remains negative for 2026, which **** ysts attribute to balance sheet stress rather than tariffs.
#august #nucor #corporation #cleveland
The volatility traces a rapid escalation. On August 19, Bloomberg reported that the US and Canada had tentatively agreed to reduce tariffs on Canadian steel and aluminum to 25% and vehicle charges to 15%. That optimism was dashed within days: on August 22, the US imposed 50% tariffs on a wide variety of Canadian exports, and Canadian Prime Minister Mark Carney responded by declaring Canada officially "at war" with the United States, saying "You're at war when you're attacked, and we got attacked."
On August 25, Ottawa announced counter-tariffs of C$27.6 billion on American goods, which took effect on September 8 at rates ranging from 15% to 50%. The dispute has continued to escalate since then, with Washington announcing additional restrictions and tariffs on Canadian goods in September, reinforcing the view that a quick resolution remains unlikely.
Atsi Sheth, Moody's chief credit officer, put it bluntly: "Expect much more of this uncertainty for some time to come." Investors initially welcomed tariffs as good news for US steelmakers facing less Canadian competition, but the back-and-forth negotiations, as well as Canada's reaction, have made predicting a steady outcome difficult.
The more intriguing story is how differently the aforementioned companies are positioned. Nucor Corporation (NYSE:NUE) relies primarily on scrap-based electric arc furnace steelmaking, while Cleveland-Cliffs Inc. (NYSE:CLF) operates a vertically integrated model with internally sourced iron ore, scrap and other raw materials. Both have meaningful domestic raw-material exposure, although their production models differ substantially. Nucor Corporation (NYSE:NUE) is up more than 50% year-to-date, while Cleveland-Cliffs Inc. (NYSE:CLF), despite similar structural insulation, remains negative for 2026, which **** ysts attribute to balance sheet stress rather than tariffs.
#august #nucor #corporation #cleveland
2 days ago
Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S. patients starting oral weight-loss medicines, a notable early gain against Novo Nordisk's Wegovy pill. Reuters reports that Wegovy initially held roughly 90% of the oral market, making Lilly's rapid share capture an important sign that the oral GLP-1 market is becoming a two-player competition rather than a Novo-dominated segment. The broader U.S. obesity-drug market is expected to exceed $100 billion annually by 2030, with oral treatments potentially accounting for more than one-third of GLP-1 use.
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and **** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.
#patients #weight #c
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and **** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.
#patients #weight #c
2 days ago
The Nasdaq 100 initially pulled back a bit during the early part of the trading session on Tuesday, but showed signs of life and looks very much like a market that is stuck in a range at the moment. This makes a certain amount of sense because we do get the Federal Reserve interest rate decision on Wednesday, but more importantly, we get the press conference.
A hike of 25 basis points is expected. That, in and of itself, probably will not move much. It is the tone of the press conference that will be the real tell.
The Dow Jones 30 initially fell but seems to be finding support at 52,000 again, an area that has previously been both support and resistance. Above, it looks like the 50-day EMA is trying to act as resistance. We are approaching an oversold condition on the stochastic oscillator, but with the 10-year yield at 5%, it makes a certain amount of sense that we struggle a bit.
The S&P 500 continues to hang around the 7,600 level. This is an area that previously had been significant resistance. It now looks as if it is trying to offer support yet again. The 50-day EMA is in this neighborhood, and the market almost certainly will be waiting to see what Kevin Warsh has to say tomorrow.
With that being the case, things look somewhat neutral here. Longer term, I am still bullish until something completely changes. At this point, though, I will be looking to see whether or not we get any type of upward momentum.
#looks #makes #certain
A hike of 25 basis points is expected. That, in and of itself, probably will not move much. It is the tone of the press conference that will be the real tell.
The Dow Jones 30 initially fell but seems to be finding support at 52,000 again, an area that has previously been both support and resistance. Above, it looks like the 50-day EMA is trying to act as resistance. We are approaching an oversold condition on the stochastic oscillator, but with the 10-year yield at 5%, it makes a certain amount of sense that we struggle a bit.
The S&P 500 continues to hang around the 7,600 level. This is an area that previously had been significant resistance. It now looks as if it is trying to offer support yet again. The 50-day EMA is in this neighborhood, and the market almost certainly will be waiting to see what Kevin Warsh has to say tomorrow.
With that being the case, things look somewhat neutral here. Longer term, I am still bullish until something completely changes. At this point, though, I will be looking to see whether or not we get any type of upward momentum.
#looks #makes #certain
2 days ago
Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S. patients starting oral weight-loss medicines, a notable early gain against Novo Nordisk's Wegovy pill. Reuters reports that Wegovy initially held roughly 90% of the oral market, making Lilly's rapid share capture an important sign that the oral GLP-1 market is becoming a two-player competition rather than a Novo-dominated segment. The broader U.S. obesity-drug market is expected to exceed $100 billion annually by 2030, with oral treatments potentially accounting for more than one-third of GLP-1 use.
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and ***** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.
#weight
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and ***** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.
#weight
2 days ago
The Nasdaq 100 initially pulled back a bit during the early part of the trading session on Tuesday, but showed signs of life and looks very much like a market that is stuck in a range at the moment. This makes a certain amount of sense because we do get the Federal Reserve interest rate decision on Wednesday, but more importantly, we get the press conference.
A hike of 25 basis points is expected. That, in and of itself, probably will not move much. It is the tone of the press conference that will be the real tell.
The Dow Jones 30 initially fell but seems to be finding support at 52,000 again, an area that has previously been both support and resistance. Above, it looks like the 50-day EMA is trying to act as resistance. We are approaching an oversold condition on the stochastic oscillator, but with the 10-year yield at 5%, it makes a certain amount of sense that we struggle a bit.
The S&P 500 continues to hang around the 7,600 level. This is an area that previously had been significant resistance. It now looks as if it is trying to offer support yet again. The 50-day EMA is in this neighborhood, and the market almost certainly will be waiting to see what Kevin Warsh has to say tomorrow.
With that being the case, things look somewhat neutral here. Longer term, I am still bullish until something completely changes. At this point, though, I will be looking to see whether or not we get any type of upward momentum.
#initially
A hike of 25 basis points is expected. That, in and of itself, probably will not move much. It is the tone of the press conference that will be the real tell.
The Dow Jones 30 initially fell but seems to be finding support at 52,000 again, an area that has previously been both support and resistance. Above, it looks like the 50-day EMA is trying to act as resistance. We are approaching an oversold condition on the stochastic oscillator, but with the 10-year yield at 5%, it makes a certain amount of sense that we struggle a bit.
The S&P 500 continues to hang around the 7,600 level. This is an area that previously had been significant resistance. It now looks as if it is trying to offer support yet again. The 50-day EMA is in this neighborhood, and the market almost certainly will be waiting to see what Kevin Warsh has to say tomorrow.
With that being the case, things look somewhat neutral here. Longer term, I am still bullish until something completely changes. At this point, though, I will be looking to see whether or not we get any type of upward momentum.
#initially
2 days ago
WASHINGTON (AP) — Republican Sen. Mitch McConnell of Kentucky returned to the Senate to vote on Monday for the first time in three months, looking noticeably more frail after he was hospitalized for a June fall in his home.
McConnell's lengthy absence from the Senate generated a flood of criticism and online speculation, as he initially remained quiet for weeks about his condition. The 84-year-old senator eventually disclosed a month later that he had been "briefly unconscious" due to the fall and had also been treated for mild pneumonia in the hospital.
He briefly addressed reporters Monday from a wheelchair outside the Senate chamber, smiling but speaking slowly and with some difficulty. McConnell joked that he wasn't sure how many reporters would be there after dodging so many questions during his almost two decades as leader.
He said he was back in the Senate to work on a pending farm bill and because he has an ongoing interest in NATO and "backing up our good friends who are totally in the fight against the Russians."
Reporters and photographers were told by Senate staff not to take video of his remarks in the second-floor hallway, even though video is often permitted in that area. Still images were allowed.
#mcconnell
McConnell's lengthy absence from the Senate generated a flood of criticism and online speculation, as he initially remained quiet for weeks about his condition. The 84-year-old senator eventually disclosed a month later that he had been "briefly unconscious" due to the fall and had also been treated for mild pneumonia in the hospital.
He briefly addressed reporters Monday from a wheelchair outside the Senate chamber, smiling but speaking slowly and with some difficulty. McConnell joked that he wasn't sure how many reporters would be there after dodging so many questions during his almost two decades as leader.
He said he was back in the Senate to work on a pending farm bill and because he has an ongoing interest in NATO and "backing up our good friends who are totally in the fight against the Russians."
Reporters and photographers were told by Senate staff not to take video of his remarks in the second-floor hallway, even though video is often permitted in that area. Still images were allowed.
#mcconnell
4 days ago
NORMAN — Oklahoma received some positive injury news Monday.
During an appearance on his coach's show, Brent Venables said linebacker Kip Lewis, who exited Saturday's loss to Michigan with an apparent knee injury, might be back sooner rather than later.
"I think we got maybe some good news and he'll be back sooner than maybe we initially thought," Venables said.
Lewis, one of the Sooners' captains and their leading tackler a season ago, was missed in the second half against the Wolverines.
It's expected Cole Sullivan, who has mostly been playing Venables' hybrid cheetah position, is expected to start in Lewis' place if he's not able to play against New Mexico. Third-year linebacker James Nesta replaced Lewis and held his own.
#injury #maybe #expected #oklahoma
During an appearance on his coach's show, Brent Venables said linebacker Kip Lewis, who exited Saturday's loss to Michigan with an apparent knee injury, might be back sooner rather than later.
"I think we got maybe some good news and he'll be back sooner than maybe we initially thought," Venables said.
Lewis, one of the Sooners' captains and their leading tackler a season ago, was missed in the second half against the Wolverines.
It's expected Cole Sullivan, who has mostly been playing Venables' hybrid cheetah position, is expected to start in Lewis' place if he's not able to play against New Mexico. Third-year linebacker James Nesta replaced Lewis and held his own.
#injury #maybe #expected #oklahoma
4 days ago
Could Tamin Lipsey return to Iowa State for another season of college basketball?
The standout point guard has joined a growing list of athletes who are suing the NCAA with hopes of gaining an additional fifth year of eligibility. Court documents indicate Lipsey may return to the Cyclones if given a chance.
Lipsey was among a batch of approximately 90 athletes who entered a class-action lawsuit filed in the state of Indiana against the NCAA. Across the country, many athletes in various sports are suing the NCAA in an effort to get a fifth year of eligibility.
In June, the NCAA Division I Cabinet unanimously approved a new five-year, age-based eligibility model, also known as the "five-for-five rule," which went into effect starting with the 2026-27 academic year. The new rule provides student-athletes across all sports with five years of eligibility over five seasons.
Under the new guidelines, each player's eligibility clock begins upon initial full-time college enrollment or at the beginning of the academic year following the athlete's 19th birthday, whichever occurs first. The "five-for-five rule" pertained to those enrolled in colleges for the 2026-27 school year. So those who concluded their collegiate careers in 2026, particularly high school athletes who graduated in 2022 and played four years of college without redshirting, were initially not included by the NCAA's new ruling.
#year #athletes #college #state
The standout point guard has joined a growing list of athletes who are suing the NCAA with hopes of gaining an additional fifth year of eligibility. Court documents indicate Lipsey may return to the Cyclones if given a chance.
Lipsey was among a batch of approximately 90 athletes who entered a class-action lawsuit filed in the state of Indiana against the NCAA. Across the country, many athletes in various sports are suing the NCAA in an effort to get a fifth year of eligibility.
In June, the NCAA Division I Cabinet unanimously approved a new five-year, age-based eligibility model, also known as the "five-for-five rule," which went into effect starting with the 2026-27 academic year. The new rule provides student-athletes across all sports with five years of eligibility over five seasons.
Under the new guidelines, each player's eligibility clock begins upon initial full-time college enrollment or at the beginning of the academic year following the athlete's 19th birthday, whichever occurs first. The "five-for-five rule" pertained to those enrolled in colleges for the 2026-27 school year. So those who concluded their collegiate careers in 2026, particularly high school athletes who graduated in 2022 and played four years of college without redshirting, were initially not included by the NCAA's new ruling.
#year #athletes #college #state
4 days ago
As you may have heard, Pete Alonso returned with his new team to Citi Field tonight, and the Mets lost to the Orioles 2-1. Although Jonah Tong pitched admirably, the Mets could not capitalize on their six hits and left nine runners on base.
After Jonah Tong struck out Dylan Beavers to lead off the first inning, Alonso stepped up to thunderous applause, cheers, and chants of his name. He flied out to Carson Benge in right field, but that did not dampen the enthusiasm of the crowd. Tong then retired Gunnar Henderson as well for a 1-2-3 start to his day. In the bottom of the inning, Francisco Lindor walked to lead off, but Juan Soto popped out, and Bo Bichette grounded into a double play for the second and third outs to end the inning.
At the top of the second inning, Jackson Holliday looped a one-out single into right field. He reached second on a passed ball by Francisco Alvarez, which had popped out of Alvarez's glove. It proved costly when Heston Kjerstad drilled a double into right field past Brett Baty. The ball made a weird hop past Baty, and Holliday scored the first run of the game. When the Mets came to bat in the second, they loaded the bases with two outs. Marcus Semien drilled a single down the left-field line, and then A.J. Ewing and Baty walked. Unfortunately, they were all stranded when Alvarez struck out on a foul tip for the third out, and the second inning ended with the score Orioles 1, Mets 0.
Alonso drew a two-out walk in the third inning, but was stranded there when Tong struck out Henderson. At the bottom of the third, Juan Soto smacked a one-out single into right field. Benge sneaked a single past third base, but both runners were again stranded when Jared Young grounded out for the third out. At the top of the fourth inning, Holliday hit a ground ball straight to Semien, but Semien could not get it out of his glove in a timely manner, and Holliday made it to first base safely. He was stranded as well, though. At the bottom of the inning, Ewing drilled a home run into right field. Alvarez smacked a ground ball to third base that Coby Mayo initially fielded but bobbled, allowing Alvarez to reach base safely on an infield hit. However, he was also stranded when Lindor struck out, leaving the score Mets 1, Orioles 1, at the end of the fourth inning.
To lead off the fifth inning, Colton Cowser hit a single that Semien knocked down but couldn't get to first base in time. The next three batters went down in order. Soto walked to lead off the bottom of the fifth and, with two outs, stole second base. Young also drew a walk, but Semien grounded out to end the rally attempt there. Tong came back out for the top of the sixth inning and only needed six pitches to retire the three batters he saw. Josh Walker replaced Brandon Young for the Orioles at the bottom of the sixth, and he also worked a 1-2-3 inning. The score remained 1-1.
#field
After Jonah Tong struck out Dylan Beavers to lead off the first inning, Alonso stepped up to thunderous applause, cheers, and chants of his name. He flied out to Carson Benge in right field, but that did not dampen the enthusiasm of the crowd. Tong then retired Gunnar Henderson as well for a 1-2-3 start to his day. In the bottom of the inning, Francisco Lindor walked to lead off, but Juan Soto popped out, and Bo Bichette grounded into a double play for the second and third outs to end the inning.
At the top of the second inning, Jackson Holliday looped a one-out single into right field. He reached second on a passed ball by Francisco Alvarez, which had popped out of Alvarez's glove. It proved costly when Heston Kjerstad drilled a double into right field past Brett Baty. The ball made a weird hop past Baty, and Holliday scored the first run of the game. When the Mets came to bat in the second, they loaded the bases with two outs. Marcus Semien drilled a single down the left-field line, and then A.J. Ewing and Baty walked. Unfortunately, they were all stranded when Alvarez struck out on a foul tip for the third out, and the second inning ended with the score Orioles 1, Mets 0.
Alonso drew a two-out walk in the third inning, but was stranded there when Tong struck out Henderson. At the bottom of the third, Juan Soto smacked a one-out single into right field. Benge sneaked a single past third base, but both runners were again stranded when Jared Young grounded out for the third out. At the top of the fourth inning, Holliday hit a ground ball straight to Semien, but Semien could not get it out of his glove in a timely manner, and Holliday made it to first base safely. He was stranded as well, though. At the bottom of the inning, Ewing drilled a home run into right field. Alvarez smacked a ground ball to third base that Coby Mayo initially fielded but bobbled, allowing Alvarez to reach base safely on an infield hit. However, he was also stranded when Lindor struck out, leaving the score Mets 1, Orioles 1, at the end of the fourth inning.
To lead off the fifth inning, Colton Cowser hit a single that Semien knocked down but couldn't get to first base in time. The next three batters went down in order. Soto walked to lead off the bottom of the fifth and, with two outs, stole second base. Young also drew a walk, but Semien grounded out to end the rally attempt there. Tong came back out for the top of the sixth inning and only needed six pitches to retire the three batters he saw. Josh Walker replaced Brandon Young for the Orioles at the bottom of the sixth, and he also worked a 1-2-3 inning. The score remained 1-1.
#field
4 days ago
Sep. 14—GRAND FORKS — UND's coaching staff has gotten its first few looks at the 2026-27 hockey team.
Due to NCAA rule changes, coaches can be on the ice with the team earlier than in the past.
"We're working out some kinks and getting the rust off," UND second-year head coach Dane Jackson said. "The professionalism, preparedness, focus and mindset of our guys has been very good. They all seem to have a real passion to come to the rink and are excited to be working. We've been really happy with the work we've been getting done."
Players initially returned to Grand Forks in July. They skated on their own for about five weeks.
Now, the coaches are working to implement systems and to sharpen details.
#working #coaches #ncaa
Due to NCAA rule changes, coaches can be on the ice with the team earlier than in the past.
"We're working out some kinks and getting the rust off," UND second-year head coach Dane Jackson said. "The professionalism, preparedness, focus and mindset of our guys has been very good. They all seem to have a real passion to come to the rink and are excited to be working. We've been really happy with the work we've been getting done."
Players initially returned to Grand Forks in July. They skated on their own for about five weeks.
Now, the coaches are working to implement systems and to sharpen details.
#working #coaches #ncaa
4 days ago
UFC 331 has lost a main card fight.
Brian Ortega is out of his scheduled bout vs. Renato Moicano due to injury and will not be replaced, the promotion announced Monday, just five days before Saturday's event at Crypto.com Arena in Los Angeles.
Instead, Moicano (21-7-1 MMA, 13-7 UFC) will now headline UFC Fight Night 292 vs. Tom Nolan (11-1 MMA, 5-1 UFC). The event takes place Oct. 31 at Meta APEX in Las Vegas.
No official injury was revealed for Ortega (16-5 MMA, 8-5 UFC), however an Instagram story posted Sunday by Christian rapper Lecrae showed the UFC contender sporting what appeared to be some fairly significant damage around his left eye area.
The change marks the second time Ortega vs. Moicano 2 has been canceled in 2026. It was initially scheduled for March and Ortega withdrew due to injury. Moicano then fought Chris Duncan, who he submitted in Round 2.
#moicano #renato
Brian Ortega is out of his scheduled bout vs. Renato Moicano due to injury and will not be replaced, the promotion announced Monday, just five days before Saturday's event at Crypto.com Arena in Los Angeles.
Instead, Moicano (21-7-1 MMA, 13-7 UFC) will now headline UFC Fight Night 292 vs. Tom Nolan (11-1 MMA, 5-1 UFC). The event takes place Oct. 31 at Meta APEX in Las Vegas.
No official injury was revealed for Ortega (16-5 MMA, 8-5 UFC), however an Instagram story posted Sunday by Christian rapper Lecrae showed the UFC contender sporting what appeared to be some fairly significant damage around his left eye area.
The change marks the second time Ortega vs. Moicano 2 has been canceled in 2026. It was initially scheduled for March and Ortega withdrew due to injury. Moicano then fought Chris Duncan, who he submitted in Round 2.
#moicano #renato
4 days ago
For much of the past year, the "AI trade" has been focused on infrastructure: processors, data centers, and cloud capacity. Snowflake Inc. (NYSE:SNOW)'s blowout quarter, which was reported after the market closed on September 2, provided something unique: clear evidence that AI is translating into real, incremental spending within software companies that are closer to the end customer. The reaction echoed throughout corporate software the next morning, adding to a rally that, for Salesforce, Inc. (NYSE:CRM) in particular, had already begun for its own reasons.
Snowflake Inc. (NYSE:SNOW) boosted its fiscal 2027 product revenues target to $6.07 billion from $5.84 billion, following a 37% increase in second-quarter product revenue to $1.49 billion. CEO Sridhar Ramaswamy stated that the company's AI products accounted for around half of that growth acceleration, which ****** ysts took as implying that AI demand is increasing Snowflake's core data platform, instead of just adoption of standalone AI add-ons. UBS ****** yst Karl Keirstead said the figures, together with Palantir and Databricks' rapid growth, gave compelling proof of robust enterprise AI adoption.
Snowflake's beat rippled across enterprise software, with ServiceNow, Atlassian, Adobe, Intuit, and Salesforce, Inc. (NYSE:CRM) all up 3.5% to 6% on the same day, while the sector-wide iShares Expanded Tech-Software ETF rose 3%.
That Snowflake-driven spike was piled on top of a much bigger adjustment made by Salesforce, Inc. (NYSE:CRM) on its own. The company released its second-quarter fiscal 2027 results on August 26, a week before Snowflake Inc. (NYSE:SNOW), with revenue of $11.35 billion, up 11% year-over-year, with current remaining performance obligations up 14% to $33.5 billion and adjusted EPS of $5.90, exceeding the $3.27 consensus. Along with those results, Salesforce and Anthropic announced Claudeforce, an expanded partnership that initially brings Salesforce data, workflows and business logic directly into Claude through a plugin with 37 prebuilt sales skills. The companies plan additional integrations across Claude, Salesforce and Slack. That said, Salesforce recorded $2.61 billion in net gains on strategic investments during the quarter, which added $2.53 per share to non-GAAP EPS.
Taken together, the two events suggest that enterprise AI adoption can increase the value and consumption of established software platforms when AI is connected to existing corporate data and workflows
#billion #software #data #quarter
Snowflake Inc. (NYSE:SNOW) boosted its fiscal 2027 product revenues target to $6.07 billion from $5.84 billion, following a 37% increase in second-quarter product revenue to $1.49 billion. CEO Sridhar Ramaswamy stated that the company's AI products accounted for around half of that growth acceleration, which ****** ysts took as implying that AI demand is increasing Snowflake's core data platform, instead of just adoption of standalone AI add-ons. UBS ****** yst Karl Keirstead said the figures, together with Palantir and Databricks' rapid growth, gave compelling proof of robust enterprise AI adoption.
Snowflake's beat rippled across enterprise software, with ServiceNow, Atlassian, Adobe, Intuit, and Salesforce, Inc. (NYSE:CRM) all up 3.5% to 6% on the same day, while the sector-wide iShares Expanded Tech-Software ETF rose 3%.
That Snowflake-driven spike was piled on top of a much bigger adjustment made by Salesforce, Inc. (NYSE:CRM) on its own. The company released its second-quarter fiscal 2027 results on August 26, a week before Snowflake Inc. (NYSE:SNOW), with revenue of $11.35 billion, up 11% year-over-year, with current remaining performance obligations up 14% to $33.5 billion and adjusted EPS of $5.90, exceeding the $3.27 consensus. Along with those results, Salesforce and Anthropic announced Claudeforce, an expanded partnership that initially brings Salesforce data, workflows and business logic directly into Claude through a plugin with 37 prebuilt sales skills. The companies plan additional integrations across Claude, Salesforce and Slack. That said, Salesforce recorded $2.61 billion in net gains on strategic investments during the quarter, which added $2.53 per share to non-GAAP EPS.
Taken together, the two events suggest that enterprise AI adoption can increase the value and consumption of established software platforms when AI is connected to existing corporate data and workflows
#billion #software #data #quarter
4 days ago
The Detroit Lions will be without Isiah Pacheco considerably longer than originally hoped.
Dan Campbell revealed Monday that the veteran running back underwent surgery and will be "out awhile." Campbell did not specify whether the procedure addressed Pacheco's knee or back, the two injuries that derailed his first training camp in Detroit.
That is a rough turn for a player the Lions signed in March expecting him to provide a physical complement to Jahmyr Gibbs. Pacheco arrived in Detroit after four seasons with Kansas City, where he rushed for 2,537 yards and won two Super Bowls.
Pacheco initially suffered a sprained MCL during training camp. At the time, Campbell believed the Lions had avoided a major problem, something we covered when Detroit first received encouraging news on the injury.
The knee later improved, but a back issue emerged late in camp and became the larger concern. Detroit ultimately placed Pacheco on injured reserve before Week 1, guaranteeing he would miss at least the first four games.
#detroit #campbell #four
Dan Campbell revealed Monday that the veteran running back underwent surgery and will be "out awhile." Campbell did not specify whether the procedure addressed Pacheco's knee or back, the two injuries that derailed his first training camp in Detroit.
That is a rough turn for a player the Lions signed in March expecting him to provide a physical complement to Jahmyr Gibbs. Pacheco arrived in Detroit after four seasons with Kansas City, where he rushed for 2,537 yards and won two Super Bowls.
Pacheco initially suffered a sprained MCL during training camp. At the time, Campbell believed the Lions had avoided a major problem, something we covered when Detroit first received encouraging news on the injury.
The knee later improved, but a back issue emerged late in camp and became the larger concern. Detroit ultimately placed Pacheco on injured reserve before Week 1, guaranteeing he would miss at least the first four games.
#detroit #campbell #four
4 days ago
The Jacksonville Jaguars received a scare involving one of their most important offensive players during Sunday's NFL Week 1 win over the Cleveland Browns. Brian Thomas Jr. left the game in the second quarter with a shoulder injury and initially was listed as questionable to return, creating immediate concern for a Jacksonville offense that had already jumped out to a big lead.
Fortunately, the latest update is much more encouraging than it initially appeared, and the Jaguars came away with a 34-10 victory over Cleveland.
MORE: 3 NFL teams that should be worried after Week 1
Jacksonville Jaguars wide receiver Brian Thomas Jr. (7) catches a pass during the first day of NFL Training Camp at the Miller Electric Center on Wednesday, July 29, 2026, in Jacksonville, Fla.
Thomas headed to the locker room with Jacksonville's medical staff after apparently injuring his shoulder. The Jaguars announced that he was questionable to return, and he had already made an impact before leaving, catching all three of his targets for 40 yards.
#cleveland
Fortunately, the latest update is much more encouraging than it initially appeared, and the Jaguars came away with a 34-10 victory over Cleveland.
MORE: 3 NFL teams that should be worried after Week 1
Jacksonville Jaguars wide receiver Brian Thomas Jr. (7) catches a pass during the first day of NFL Training Camp at the Miller Electric Center on Wednesday, July 29, 2026, in Jacksonville, Fla.
Thomas headed to the locker room with Jacksonville's medical staff after apparently injuring his shoulder. The Jaguars announced that he was questionable to return, and he had already made an impact before leaving, catching all three of his targets for 40 yards.
#cleveland
4 days ago
Comedian Bill Maher called Democratic politicians "cowards" while doubling down on his stance that the Sept. 11, 2001, hijackers were not — a position that infamously led to ABC canceling his show more than two decades ago.
In a segment on HBO's "Real Time with Bill Maher" Friday, the comedian reaffirmed his opinion that "the terrorists weren't cowards" which he initially said after the Sept. 11 terrorist attacks.
"I know a guy whose show got canceled just for saying the terrorists weren't cowards. And that guy was right. They weren't cowards, but I'll tell you who is: Democratic Party politicians," Maher said.
He added that this "moral confusion" within the party is most notable when talking about "a place called Gaza."
"A little strip of land that was not part of the original Israel, but which they won in a war launched against them, but then gave back as a peace gesture," he said.
#cowards #democratic #called #politicians
In a segment on HBO's "Real Time with Bill Maher" Friday, the comedian reaffirmed his opinion that "the terrorists weren't cowards" which he initially said after the Sept. 11 terrorist attacks.
"I know a guy whose show got canceled just for saying the terrorists weren't cowards. And that guy was right. They weren't cowards, but I'll tell you who is: Democratic Party politicians," Maher said.
He added that this "moral confusion" within the party is most notable when talking about "a place called Gaza."
"A little strip of land that was not part of the original Israel, but which they won in a war launched against them, but then gave back as a peace gesture," he said.
#cowards #democratic #called #politicians
4 days ago
After briefly exiting Sunday's win over the Cleveland Browns, Jacksonville Jaguars' head coach Liam Coen fully expects wide receiver Brian Thomas Jr. to be available in Week 2 against Denver -- although he may be limited during the week of upcoming practices.
"I fully imagine him being able to play this game," Coen said on Monday. "No issues, just might not be able to get hit throughout the week or something."
Thomas Jr. left the Jaguars' Week 1 win in the first half with a shoulder injury. He was initially questionable to return, but did go back into the game.
Thomas Jr. finished the game with three receptions for 40 yards.
He also sustained a shoulder injury in the Jaguars' first joint practice with the Tampa Bay Buccaneers. Whether or not that injury and the current one are related has not been reported.
#fully #able #shoulder
"I fully imagine him being able to play this game," Coen said on Monday. "No issues, just might not be able to get hit throughout the week or something."
Thomas Jr. left the Jaguars' Week 1 win in the first half with a shoulder injury. He was initially questionable to return, but did go back into the game.
Thomas Jr. finished the game with three receptions for 40 yards.
He also sustained a shoulder injury in the Jaguars' first joint practice with the Tampa Bay Buccaneers. Whether or not that injury and the current one are related has not been reported.
#fully #able #shoulder
4 days ago
WASHINGTON (AP) — President Donald Trump has agreed to a significant portion of a stringent ethics proposal that is part of broader cryptocurrency legislation headed for a key vote this week, according to three of the bill's main Republican authors.
The sweeping bill initially had just a provision included that would bar all federally elected officials and their spouses, as well as federal judges, from issuing digital ***** ets.
A core group of Democrats, as well as Sen. Thom Tillis, R-N.C., said that didn't go far enough to address conflict-of-interest issues they had with Trump's crypto wealth. Their votes would be needed to advance the bill in a key vote this Tuesday.
Tillis and Sen. Ruben Gallego, D-Ariz., along with several other Democrats, had demanded language that would allow state attorneys general to step in and enforce the law in addition to the Justice Department.
In announcing Trump's agreement, Republican Sens. Cynthia Lummis of Wyoming, Tim Scott of South Carolina and John Boozman of Arkansas said it includes a "meaningful role" for state attorneys general to play in enforcing the crypto measure should it become law.
#republican #vote #well #Crypto
The sweeping bill initially had just a provision included that would bar all federally elected officials and their spouses, as well as federal judges, from issuing digital ***** ets.
A core group of Democrats, as well as Sen. Thom Tillis, R-N.C., said that didn't go far enough to address conflict-of-interest issues they had with Trump's crypto wealth. Their votes would be needed to advance the bill in a key vote this Tuesday.
Tillis and Sen. Ruben Gallego, D-Ariz., along with several other Democrats, had demanded language that would allow state attorneys general to step in and enforce the law in addition to the Justice Department.
In announcing Trump's agreement, Republican Sens. Cynthia Lummis of Wyoming, Tim Scott of South Carolina and John Boozman of Arkansas said it includes a "meaningful role" for state attorneys general to play in enforcing the crypto measure should it become law.
#republican #vote #well #Crypto
4 days ago
Glentoran manager Declan Devine is set to leave the club amid the east Belfast outfit's poor start to the Irish Premiership season.
An agreement over his departure was reached on Monday with the Glens winless in their past three league games and sat eighth in the table with seven points from their opening six fixtures.
Devine's last game in charge was a frustrating 1-1 draw with Bangor at the Oval on Saturday and the full-time whistle was met by a chorus of boos from the home faithful.
Former Glens goalkeeper Devine took over at the 23-time league champions initially as interim boss in March 2024 after Warren Feeney was sacked.
He was given the role as permanent boss the following month and guided Glentoran to the County Antrim Shield in the 2024-25 season, their first trophy in five years.
#glentoran #declan
An agreement over his departure was reached on Monday with the Glens winless in their past three league games and sat eighth in the table with seven points from their opening six fixtures.
Devine's last game in charge was a frustrating 1-1 draw with Bangor at the Oval on Saturday and the full-time whistle was met by a chorus of boos from the home faithful.
Former Glens goalkeeper Devine took over at the 23-time league champions initially as interim boss in March 2024 after Warren Feeney was sacked.
He was given the role as permanent boss the following month and guided Glentoran to the County Antrim Shield in the 2024-25 season, their first trophy in five years.
#glentoran #declan
4 days ago
Kylie Jenner sold her Hidden Hills, Calif., mansion for $15.3 million after initially listing it for $20.25 million in March
The 13,000-square-foot property includes eight bedrooms, a private theater, a pool and a guest residence
Jenner is building a new "dream Italian home" on a five-acre plot she reportedly purchased in 2020 for $15 million
Kylie Jenner has officially sold her longtime Southern California mansion.
According to the listing — which was held by Million Dollar Listing alums Josh and Matt Altman of Douglas Elliman — the sprawling Hidden Hills home was sold for $15.3 million. Property records indicate the sale was completed on Friday, Sept. 11.
#jenner
The 13,000-square-foot property includes eight bedrooms, a private theater, a pool and a guest residence
Jenner is building a new "dream Italian home" on a five-acre plot she reportedly purchased in 2020 for $15 million
Kylie Jenner has officially sold her longtime Southern California mansion.
According to the listing — which was held by Million Dollar Listing alums Josh and Matt Altman of Douglas Elliman — the sprawling Hidden Hills home was sold for $15.3 million. Property records indicate the sale was completed on Friday, Sept. 11.
#jenner
4 days ago
It's always tough navigating that first injury report coming out of preseason and training camp. Some injuries are downplayed and others weren't as serious as initially thought. We also get some surprises (we're looking at you Raiders and Brock Bowers).
But we've gotten through most of the action for Week 1 and can lookahead to which injuries we'll need to track going into the second slate of the season. Below is all the latest news and updates, plus some fantasy football ******* ysis to help with weekly lineup tinkering.
Kyler Murray, MIN (concussion)
Sam Darnold, SEA (hip)
Murray: It was a tough Minnesota debut for Murray, exiting early in the contest after a questionable hit from Packers S Javon Bullard. Prior to the hit, Murray had thrown an egregious interception into triple coverage. Murray did not return, finishing the game 3-for-5 for 18 yards and the INT, plus two carries for nine yards.
#bowers
But we've gotten through most of the action for Week 1 and can lookahead to which injuries we'll need to track going into the second slate of the season. Below is all the latest news and updates, plus some fantasy football ******* ysis to help with weekly lineup tinkering.
Kyler Murray, MIN (concussion)
Sam Darnold, SEA (hip)
Murray: It was a tough Minnesota debut for Murray, exiting early in the contest after a questionable hit from Packers S Javon Bullard. Prior to the hit, Murray had thrown an egregious interception into triple coverage. Murray did not return, finishing the game 3-for-5 for 18 yards and the INT, plus two carries for nine yards.
#bowers
4 days ago
Marriott International, Inc. (NASDAQ:MAR)'s Middle East business showed a meaningful improvement in July, with revenue per available room (RevPAR) declining 12% year over year, a sharp improvement from the 43% decline in the second quarter. The improvement came despite continued regional conflict, suggesting that demand is proving more resilient than initially feared. More importantly, Marriott's global business remains strong: global room revenue increased 7% in July, with the U.S. and Canada up 8%.
However, the Middle East remains a risk to Marriott International, Inc. (NASDAQ:MAR)'s growth strategy. The region represents only about 3% of Marriott's global fees but 6% of its development pipeline, meaning prolonged conflict can have an outsized impact on future hotel openings. Supply-chain disruptions and restricted capital flows have already delayed projects, pushing Marriott toward the lower end of its full-year net unit growth target.
The biggest positive is that the Middle East headwind appears to be easing faster than expected. Moving from a 43% RevPAR decline in the second quarter to just 12% in July suggests travel demand can recover even as geopolitical risks remain elevated. If the conflict stabilizes, Marriott International, Inc. (NASDAQ:MAR) could see a relatively quick rebound in regional occupancy and room rates.
More importantly, the Middle East is not large enough to overwhelm Marriott's broader global performance. The company generated a 7% increase in global room revenue in July, while U.S. and Canadian room revenue rose 8%. RevPAR growth was also broad-based across luxury, premium/select and mid-scale brands, suggesting that Marriott's strength is not dependent solely on wealthy travelers.
Marriott also benefits from an ***** et-light, fee-driven model, meaning stronger hotel demand can translate into attractive cash generation without requiring the company to own most of the underlying properties. Barron's has highlighted the resilience of this model, alongside the strength of Marriott Bonvoy and additional growth opportunities from its credit-card partnerships.
#marriott #middle #room
However, the Middle East remains a risk to Marriott International, Inc. (NASDAQ:MAR)'s growth strategy. The region represents only about 3% of Marriott's global fees but 6% of its development pipeline, meaning prolonged conflict can have an outsized impact on future hotel openings. Supply-chain disruptions and restricted capital flows have already delayed projects, pushing Marriott toward the lower end of its full-year net unit growth target.
The biggest positive is that the Middle East headwind appears to be easing faster than expected. Moving from a 43% RevPAR decline in the second quarter to just 12% in July suggests travel demand can recover even as geopolitical risks remain elevated. If the conflict stabilizes, Marriott International, Inc. (NASDAQ:MAR) could see a relatively quick rebound in regional occupancy and room rates.
More importantly, the Middle East is not large enough to overwhelm Marriott's broader global performance. The company generated a 7% increase in global room revenue in July, while U.S. and Canadian room revenue rose 8%. RevPAR growth was also broad-based across luxury, premium/select and mid-scale brands, suggesting that Marriott's strength is not dependent solely on wealthy travelers.
Marriott also benefits from an ***** et-light, fee-driven model, meaning stronger hotel demand can translate into attractive cash generation without requiring the company to own most of the underlying properties. Barron's has highlighted the resilience of this model, alongside the strength of Marriott Bonvoy and additional growth opportunities from its credit-card partnerships.
#marriott #middle #room
4 days ago
Howmet Aerospace Inc. (NYSE:HWM) is facing a mixed outlook after GE Aerospace agreed to acquire Consolidated Precision Products (CPP) for about $11.75 billion to secure more control over critical engine castings and expand production capacity. The announcement initially hit Howmet shares, which fell about 10%, as investors worried that GE could eventually rely less on outside suppliers such as Howmet.
However, Howmet CEO John Plant said he is comfortable with the deal and remains confident in Howmet's ability to grow. The bigger issue for Howmet right now appears to be how quickly it can expand capacity to keep up with soaring demand. Commercial aircraft production, defense activity and aftermarket demand are all increasing, while Howmet is also benefiting from demand for turbine components used in data centers. Plant said the scale of the required capital expansion is itself "testing" the company.
The strongest bullish argument for Howmet Aerospace Inc. (NYSE:HWM) is that GE's decision to spend nearly $12 billion on CPP validates how strategically valuable aerospace castings and engine components have become. The acquisition is aimed at addressing a supply bottleneck rather than signaling weak demand. GE expects airfoil demand to rise by more than 30% through 2030, while aircraft manufacturers and defense customers continue to push production higher. That creates a favorable industry backdrop for Howmet as well.
Howmet also has an opportunity to benefit from customers looking for additional capacity outside GE's newly integrated supply chain. If demand continues to exceed available casting capacity, Howmet's existing manufacturing footprint and expertise could give it significant pricing power and support further investment. Plant's comments that the company is being "tested" by the sheer scale of expansion suggest that Howmet is dealing with a capacity problem caused by strong demand, rather than a lack of orders.
Another positive is that Howmet Aerospace Inc. (NYSE:HWM)'s exposure extends beyond commercial aircraft. Its blades and vanes are also used in gas turbines serving the rapidly expanding data-center market, providing another avenue for growth alongside aerospace. Plant has also indicated that the company intends to revisit its longer-term revenue targets, after previously saying revenue could potentially double from 2025 levels within three to five years.
#commercial
However, Howmet CEO John Plant said he is comfortable with the deal and remains confident in Howmet's ability to grow. The bigger issue for Howmet right now appears to be how quickly it can expand capacity to keep up with soaring demand. Commercial aircraft production, defense activity and aftermarket demand are all increasing, while Howmet is also benefiting from demand for turbine components used in data centers. Plant said the scale of the required capital expansion is itself "testing" the company.
The strongest bullish argument for Howmet Aerospace Inc. (NYSE:HWM) is that GE's decision to spend nearly $12 billion on CPP validates how strategically valuable aerospace castings and engine components have become. The acquisition is aimed at addressing a supply bottleneck rather than signaling weak demand. GE expects airfoil demand to rise by more than 30% through 2030, while aircraft manufacturers and defense customers continue to push production higher. That creates a favorable industry backdrop for Howmet as well.
Howmet also has an opportunity to benefit from customers looking for additional capacity outside GE's newly integrated supply chain. If demand continues to exceed available casting capacity, Howmet's existing manufacturing footprint and expertise could give it significant pricing power and support further investment. Plant's comments that the company is being "tested" by the sheer scale of expansion suggest that Howmet is dealing with a capacity problem caused by strong demand, rather than a lack of orders.
Another positive is that Howmet Aerospace Inc. (NYSE:HWM)'s exposure extends beyond commercial aircraft. Its blades and vanes are also used in gas turbines serving the rapidly expanding data-center market, providing another avenue for growth alongside aerospace. Plant has also indicated that the company intends to revisit its longer-term revenue targets, after previously saying revenue could potentially double from 2025 levels within three to five years.
#commercial
4 days ago
The FedEx Cup Fall is here.
The 2026 Biltmore Championship, a new PGA Tour event in Asheville, North Carolina, kicks off Thursday. The Presidents Cup is set for next week outside of Chicago, but the first Tour event since the season-ending Tour Championship is up. The Cliffs at Walnut Grove will host the tournament. The layout is a par-71 measuring 7,249 yards.
Being a fall event, the purse is significantly smaller than most events from the regular season. The biggest name initially in the field, Justin Thomas, withdrew Sunday, too, but there are other notables set to take on the Biltmore.
Here's a look at the purse and prize money payouts for the 2026 Biltmore Championship, where $5 million is up for grabs in Asheville, North Carolina.
More: PGA Tour fall schedule includes 8 events, international competition, silly season
#biltmore #north
The 2026 Biltmore Championship, a new PGA Tour event in Asheville, North Carolina, kicks off Thursday. The Presidents Cup is set for next week outside of Chicago, but the first Tour event since the season-ending Tour Championship is up. The Cliffs at Walnut Grove will host the tournament. The layout is a par-71 measuring 7,249 yards.
Being a fall event, the purse is significantly smaller than most events from the regular season. The biggest name initially in the field, Justin Thomas, withdrew Sunday, too, but there are other notables set to take on the Biltmore.
Here's a look at the purse and prize money payouts for the 2026 Biltmore Championship, where $5 million is up for grabs in Asheville, North Carolina.
More: PGA Tour fall schedule includes 8 events, international competition, silly season
#biltmore #north
6 days ago
The dollar index (DXY00) on Friday rose by +0.06%. The dollar found support as a hawkish US CPI report pushed odds of an FOMC rate hike next week up to 88% from 75% on Thursday. Also, the 10-year T-note yield on Friday rose by +0.6 bp, supporting the dollar's interest rate differentials.
Friday's -2.4% decline in oil prices initially caused the 10-year T-note yield to drop, despite the CPI report. However, the CPI report caught up with the T-note market by the end of the day, and the 10-year T-note yield ended slightly higher.
Dollar Eases as Crude Oil Prices Fall
Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!
Friday's Aug US CPI report of +0.4% m/m was in line with market expectations, but the core CPI report of +0.3% m/m was slightly stronger than market expectations of +0.2% m/m. On a year-on-year basis, the Aug CPI report of +3.4% y/y was unchanged from July and was in line with market expectations. Meanwhile, the Aug core CPI report of +2.4% y/y eased slightly from July's +2.5% and posted a new 5.5-year low, and was in line with market expectations.
#year
Friday's -2.4% decline in oil prices initially caused the 10-year T-note yield to drop, despite the CPI report. However, the CPI report caught up with the T-note market by the end of the day, and the 10-year T-note yield ended slightly higher.
Dollar Eases as Crude Oil Prices Fall
Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!
Friday's Aug US CPI report of +0.4% m/m was in line with market expectations, but the core CPI report of +0.3% m/m was slightly stronger than market expectations of +0.2% m/m. On a year-on-year basis, the Aug CPI report of +3.4% y/y was unchanged from July and was in line with market expectations. Meanwhile, the Aug core CPI report of +2.4% y/y eased slightly from July's +2.5% and posted a new 5.5-year low, and was in line with market expectations.
#year
6 days ago
By Lucia Mutikani
WASHINGTON, Sept 11 (Reuters) - U.S. consumer prices accelerated in August, while a key measure of underlying inflation posted its largest increase in four months, reinforcing expectations that the Federal Reserve will raise interest rates next week.
The Labor Department's Consumer Price Index report on Friday followed strong readings in several components of the Producer Price Index released on Thursday that feed into the Personal Consumption Expenditures price indexes, the inflation measures the U.S. central bank tracks for its 2% target. The two reports led economists to think that PCE inflation excluding the volatile food and energy categories picked up in August.
Financial markets initially priced in a 91% chance of a quarter-point rate hike at the Fed's meeting on Tuesday and Wednesday, before settling back to 87%, CME's FedWatch tool showed. That was up from 72% on Thursday. The Fed's benchmark overnight interest rate is currently in a 3.50%-3.75% range.
Most economists said the firmer inflation readings, combined with signs of the labor market regaining its footing in August, would compel Fed officials to raise borrowing costs not only next Wednesday, but possibly again in October or December.
#Consumer
WASHINGTON, Sept 11 (Reuters) - U.S. consumer prices accelerated in August, while a key measure of underlying inflation posted its largest increase in four months, reinforcing expectations that the Federal Reserve will raise interest rates next week.
The Labor Department's Consumer Price Index report on Friday followed strong readings in several components of the Producer Price Index released on Thursday that feed into the Personal Consumption Expenditures price indexes, the inflation measures the U.S. central bank tracks for its 2% target. The two reports led economists to think that PCE inflation excluding the volatile food and energy categories picked up in August.
Financial markets initially priced in a 91% chance of a quarter-point rate hike at the Fed's meeting on Tuesday and Wednesday, before settling back to 87%, CME's FedWatch tool showed. That was up from 72% on Thursday. The Fed's benchmark overnight interest rate is currently in a 3.50%-3.75% range.
Most economists said the firmer inflation readings, combined with signs of the labor market regaining its footing in August, would compel Fed officials to raise borrowing costs not only next Wednesday, but possibly again in October or December.
#Consumer
6 days ago
The Oklahoma Sooners lost one of their very best players to injury on Saturday in their 17-10 loss against the Michigan Wolverines. In the game's first quarter, star fifth-year linebacker Kip Lewis injured his right knee, initially returning to the game with a brace on. However, he quickly exited again, and was in the sideline in street clothes for the remainder of the contest.
After the game, head coach Brent Venables gave a quick update on Lewis' status, which wasn't a positive one for the Sooners.
"He'll miss some time," Venables said.
OU struggled mightily on defense in the first half, at least relative to their standards in Norman. However, the second half was better. The Sooners gave up just seven points when they were backed up following an interception from quarterback John Mateer.
Brent Venables on #Sooners star LB Kip Lewis:
“He’ll miss some time.” pic.twitter.com/N38qMRW1ym
#Sooners
After the game, head coach Brent Venables gave a quick update on Lewis' status, which wasn't a positive one for the Sooners.
"He'll miss some time," Venables said.
OU struggled mightily on defense in the first half, at least relative to their standards in Norman. However, the second half was better. The Sooners gave up just seven points when they were backed up following an interception from quarterback John Mateer.
Brent Venables on #Sooners star LB Kip Lewis:
“He’ll miss some time.” pic.twitter.com/N38qMRW1ym
#Sooners
